Atlas Trials

Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg

Clinical trial NCT05076474 · COMPLETED

Trial details

NCT number
NCT05076474
Sponsor
Shandong New Time Pharmaceutical Co., LTD
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Bioequivalence
Start date
2020-10-01
Primary completion
2021-03-01
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.